nen introduces its first groundbreaking product
Home News nen introduces its first groundbreaking product "nendo" for pediatric pain

nen introduces its first groundbreaking product "nendo" for pediatric pain

JANUARY 25, 2024 BHH Members Initiatives

BHH member nen, a pioneer in digital health solutions, is thrilled to announce the launch of its first product, "nendo", specifically designed for children suffering from pain.

This revolutionary digital program aims to provide young patients with cancer an innovative way to address their pain through gamified behavioral techniques.

  • Science-based gaming designed for kids and with kids.
  • Helping kids rise above their pain

nendo harnesses the power of play, combining behavioral techniques and gamification, to offer a unique approach to pain management enhancing kids overall quality of life.

nendo is designed to be fun and allow kids to access nendo whenever they need it from the comfort of their homes. The platform helps children to restructure beliefs and emotional reactions to pain and improve their overall wellbeing. nendo's virtual companions introduce age-appropriate behavioral techniques for children and help to differentiate mood from pain.

Through this interactive experience, users can document their pain, moods, and comfort levels, providing valuable insight for a more personalized journey. This information not only enhances kids' experience but also equips parents with crucial insights to understand and support their children's pain management.

Francesca Domenech Wuttke, Ph.D., CEO and Founder of nen, expresses her enthusiasm: "After founding nen in February 2022, we are incredibly excited to bring nendo to families in need. Our mission-driven approach focuses on addressing pain through engaging, playful methods. By leveraging gamification and behavioral techniques, we believe nendo can help manage pain and significantly improve the well-being of these children. We are grateful for the opportunity to impact kids and their families with this novel solution, democratizing access to pain-focused approaches."

nendo is more than just a digital tool; it represents hope and support for families struggling with the challenges of childhood cancer and other conditions that cause pain in children. nen's commitment to these families goes beyond offering a product—it's about providing a companion in their journey, a source of comfort and relief in difficult times. When parents purchase nendo, they also help provide free access to other kids in need who are experiencing pain with their "buy one share one" program.

The program is available for download in the US, UK and Spain, offering easy and immediate access to families in need.

For more information about nendo and how it can help your child, please visit nen's website HERE

June 11, 2025 BHH Members Initiatives
How to reduce non-urgent surgical waiting times in Spain by going digital
Spain’s healthcare system is under pressure. Non-urgent surgical waiting times are on average 112 days, with 17.4% of patients waiting over six months.
Read more
June 10, 2025 BHH Members Initiatives
Gebro Pharma and The Ricky Rubio Foundation join forces in a joint campaign against smoking
Laboratorios Gebro Pharma and The Ricky Rubio Foundation have signed a collaboration agreement to join forces in the social awareness campaign against smoking called "Goodbye Nicotine."
Read more
June 04, 2025 BHH Members Initiatives
Join the GSK Gate2Health Open Innovation Challenge!
GSK has opened applications to three innovation challenges focused on women’s health and disease prevention.
Read more
May 29, 2025 BHH Members Initiatives
Bringing laughter to Primary Care: A Project to alleviate invisible pain
An innovative pilot project will launch this September at the CAPI Baix-a-Mar (part of the Alt Penedès-Garraf Health Consortium), aiming to support individuals with medically unexplained symptoms through the therapeutic power of humour.
Read more
May 28, 2025 BHH Members Initiatives
AstraZeneca and Idoven launch the CONCERTO project to improve early diagnosis of patients with amyloidosis
AstraZeneca and Idoven have announced the launch of CONCERTO, a project aimed at improving the early diagnosis of patients with amyloidosis.
Read more
May 21, 2025 BHH Members Initiatives
Virtual reality (VR) assisted obesity treatment: An innovative approach
This article explores how virtual reality (VR) technology is emerging as a promising tool in obesity management.
Read more
May 21, 2025 BHH Members Initiatives
HLAnalytics closes an oversubscribed €750,000 seed round to boost AI in operating rooms
This funding will enable HLAnalytics to expand its platform’s reach and continue developing innovative solutions for the healthcare sector.
Read more
May 19, 2025 BHH Members Initiatives
Break the Gap 2025: the meeting point between innovation, health, and sport
GooApps presents the second edition of its innovation event: Break the Gap: AI for Health & Sport Summit 2025, an evolution of the successful AI & mHealth Challenge.
Read more
May 19, 2025 BHH Members Initiatives
Eurecat announces its opening in Madrid.
Don't miss the opportunity to connect with Madrid's business, science, technology, and innovation ecosystem.
Read more
May 02, 2025 BHH Members Initiatives
€50M Series C for deepull, an Asabys portfolio company
deepull secures oversubscribed €50M Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection.
Read more